Urinary detection of corticosteroid in topical treatment of skin disease by 19F MRS

被引:2
|
作者
Sitter, Beathe [1 ]
机构
[1] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway
关键词
Renal; Excretion; Treatment; Skin; Betamethasone; 17-valerate; METABOLISM;
D O I
10.1007/s10334-018-00734-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectiveTo investigate if it was feasible to quantify the renal excretion of topically applied corticosteroids by F-19 MRS.Materials and methodsFive participants, one healthy and four with skin diseases, were treated with ointment containing betamethasone 17-valerate. Urine samples were collected for up to 87h after the initial application. A sample of ointment mixed with urine served as a study control. Organic fractions were obtained after sample freeze drying, and resolved in deuterated chloroform prior to acquisition of F-19 MR spectra at 470MHz for typically 8 h.ResultsWe detected fluorine signals in 40 of the 62 fractions of organic extracts. The corticosteroid was detected in samples from all patients, ranging from 0.1 to 2.8% of the applied steroid. No fluorine signal was obtained in samples from the healthy volunteer.Discussion(19)F MRS can be utilized to detect topically applied corticosteroids in urine. However, more work is required to optimize and control for extraction procedures, complete spectral assignments and reliable quantification.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [1] Urinary detection of corticosteroid in topical treatment of skin disease by 19F MRS
    Beathe Sitter
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2019, 32 : 157 - 162
  • [2] Fluorine (19F) MRS and MRI in biomedicine
    Ruiz-Cabello, Jesus
    Barnett, Brad P.
    Bottomley, Paul A.
    Bulte, Jeff W. M.
    NMR IN BIOMEDICINE, 2011, 24 (02) : 114 - 129
  • [3] Ocular pharmacokinetic study of a corticosteroid by 19F MR
    Liu, Xin
    Li, S. Kevin
    Jeong, Eun-Kee
    EXPERIMENTAL EYE RESEARCH, 2010, 91 (03) : 347 - 352
  • [4] Novel 19F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS
    Yue, Xuyi
    Wang, Zhe
    Zhu, Lei
    Wang, Yu
    Qian, Chunqi
    Ma, Ying
    Kiesewetter, Dale O.
    Niu, Gang
    Chen, Xiaoyuan
    MOLECULAR PHARMACEUTICS, 2014, 11 (11) : 4208 - 4217
  • [5] Quantitative 1H MRI, 19F MRI, and 19F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles
    Kok, Maarten B.
    de Vries, Anke
    Abdurrachim, Desiree
    Prompers, Jeanine J.
    Grull, Holger
    Nicolay, Klaas
    Strijkers, Gustav J.
    CONTRAST MEDIA & MOLECULAR IMAGING, 2011, 6 (01) : 19 - 27
  • [6] Metabolic changes in psoriatic skin under topical corticosteroid treatment
    Sitter, Beathe
    Johnsson, Margareta Karin
    Halgunset, Jostein
    Bathen, Tone Frost
    BMC DERMATOLOGY, 2013, 13
  • [7] Detection of aptamer target binding with 19F NMR
    Petersen, Katie
    Easdon, Jerry C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [8] Activatable Dendritic 19F Probes for Enzyme Detection
    Wang, Hui
    Raghupathi, Krishna R.
    Zhuang, Jiaming
    Thayumanavan, S.
    ACS MACRO LETTERS, 2015, 4 (04) : 422 - 425
  • [9] 19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles
    Jacob W Myerson
    Megan M Kaneda
    Gregory M Lanza
    Samuel A Wickline
    Journal of Cardiovascular Magnetic Resonance, 12 (Suppl 1)
  • [10] Novel 19F MRS/I Nanoprobe Based on pH-Responsive PEGylated Nanogel: pH-Dependent 19F Magnetic Resonance Studies
    Oishi, Motoi
    Sumitani, Shogo
    Bronich, Tatiana K.
    Kabanov, Alexander V.
    Boska, Michael D.
    Nagasaki, Yukio
    CHEMISTRY LETTERS, 2009, 38 (02) : 128 - 129